Studying the brain-gut axis with pharmacological imaging

Annals of the New York Academy of Sciences

Volumn 1144, Issue , 2008, Pages 256-264

  Tillisch, Kirsten ^a   Wang, Zhuo ^a,c   Kilpatrick, Lisa ^a   Holschneider, Daniel P ^b,c   Mayer, Emeran A ^a,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of Southern California ^*  (United States)

^c Greater Los Angeles Veterans Healthcare System   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain gut axis; Functional gastrointestinal disorder; Irritable bowel syndrome; Neuroimaging

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN GUT AXIS; BRAIN MAPPING; CONFERENCE PAPER; DIAGNOSTIC IMAGING; DRUG EFFICACY; ELECTROENCEPHALOGRAM; ENTERITIS; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOPHYSIS FUNCTION; IRRITABLE COLON; NERVE CELL NETWORK; NEUROIMAGING; NONHUMAN; PATHOPHYSIOLOGY; RAT;

ANIMALIA;

EID: 56649108173     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1418.025     Document Type: Conference Paper

References (50)

1. Schweinhardt, P., C. Bountra & I. Tracey. 2006. Pharmacological fMRI in the development of new analgesic compounds. NMR Biomed. 19 : 702 711.
2. Monnikes, H. et al. 2003. Differential induction of c-fos expression in brain nuclei by noxious and non-noxious colonic distension: role of afferent C-fibers and 5-HT3 receptors. Brain Res. 21 : 253 264.
3. Stam, R. et al. 2002. Long-lasting changes in central nervous system responsivity to colonic distention after stress in rats. Gastroenterology 123 : 1216 1225.
4. Traub, R.J. et al. 1996. Noxious colorectal distention induced-c-Fos protein in limbic brain structures in the rat. Neurosci. Lett. 215 : 165 168.
5. Kozlowski, C.M. et al. 2000. The 5-HT 3 receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised rat. Gut 46 : 474 480.
6. Mayer, E.A. & S.M. Collins. 2002. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology 122 : 2032 2048.
7. Furmark, T. et al. 2005. Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo. Biol. Psychiatry 58 : 132 142.
8. Fu, C.H. et al. 2004. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch. Gen. Psychiatry 61 : 877 889.
9. Abbadie, C. et al. 1996. Spinal cord substance P receptor immunoreactivity increases in both inflammatory and nerve injury models of persistent pain. Neuroscience 70 : 201 209.
10. Paulus, M.P. et al. 2005. Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing. Arch. Gen. Psychiatry 62 : 282 288.
11. Wise, R.G. et al. 2002. Combining fMRI with a pharmacokinetic model to determine which brain areas activated by painful stimulation are specifically modulated by remifentanil. Neuroimage 16 : 999 1014.
12. Iannetti, G.D. et al. 2005. Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans. Proc. Natl. Acad. Sci. USA 102 : 18195 18200.
13. Rainville, P. et al. 1997. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science 277 : 968 971.
14. Wager, T.D. et al. 2004. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science 303 : 1162 1167.
15. Petrovic, P. et al. 2002. Placebo and opioid analgesia - Imaging a shared neuronal network. Science 295 : 1737 1740.
16. Lieberman, M.D. et al. 2004. The neural correlates of placebo effects: a disruption account. Neuroimage 22 : 447 455.
17. Goldapple, K. et al. 2004. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch. Gen. Psychiatry 61 : 34 41.
18. Mayer, E.A., B.D. Naliboff & A.D. Craig. 2006. Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders. Gastroenterology 131 : 1925 1942.
19. deCharms, R.C. et al. 2005. Control over brain activation and pain learned by using real-time functional MRI. Proc. Natl. Acad. Sci. USA 102 : 18626 18631.
20. Mertz, H. et al. 2002. Amitriptyline reduces visceral sensitization and limbic activation induced by stress in IBS and improves symptoms. Gastroenterology 122 : A310.
21. Berman, S.M. et al. 2002. Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist alosetron. Gastroenterology 123 : 969 977.
22. Lackner, J.M. et al. 2004. Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis. J. Consult. Clin. Psychol. 72 : 1100 1113.
23. Pattinson, K.T. et al. 2007. Pharmacological fMRI: measuring opioid effects on the BOLD response to hypercapnia. J. Cereb. Blood Flow Metab 138 : 414 423.
24. Morgan, V. et al. 2005. Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome. Gut 54 : 601 607.
25. Kilpatrick, L. et al. 2006. A course of tegaserod treatment modulates CNS processing of visceral afferent information. Gastroenterology 130 : A-289 A-290.
26. Tillisch, K. et al. 2008. The effects of neurokinin-1 receptor antagonism on central responses to visceral pain in irritable bowel syndrome (IBS): a pilot study. Gastroenterology 134 : A545.
27. Bueller, J. et al. 2008. Effects of NK-1 receptor antagonist AV608 on emotional circuitry and affect in female IBS patients. Gastroenterology 134 : A276.
28. Bueller, J. et al. 2007. Alterations of emotional modulation in irritable bowel syndrome: An fMRI study. Gastroenterology 132 : A 72.
29. Lieberman, M.D. et al. 2007. Putting feelings into words: affect labeling disrupts amygdala activity in response to affective stimuli. Psychol. Sci. 18 : 421 428.
30. Ness, T.J. & G.F. Gebhart. 1988. Colorectal distension as a noxious visceral stimulus: physiologic and pharmacologic characterization of pseudaffective reflexes in the rat. Brain Res. 450 : 153 169.
31. Bradesi, S. et al. 2005. Repeated exposure to water avoidance stress in rats: a new model for sustained visceral hyperalgesia. Am. J. Physiol. Gastrointest. Liver Physiol. 289 : G42 53.
32. Greenwood-Van Meerveld, B. et al. 2001. Stereotaxic delivery of corticosterone to the amygdala modulates colonic sensitivity in rats. Brain Res. 893 : 135 142.
33. Nijsen, M.J. et al. 2003. Telemetric animal model to evaluate visceral pain in the freely moving rat. Pain 105 : 115 123.
34. Stam, R., T.J. van Laar & V.M. Wiegant. 2004. Physiological and behavioural responses to duodenal pain in freely moving rats. Physiol. Behav. 81 : 163 169.
35. Monnikes, H. et al. 2003. Differential induction of c-fos expression in brain nuclei by noxious and non-noxious colonic distension: role of afferent C-fibers and 5-HT3 receptors. Brain Res. 966 : 253 264.
36. Kozlowski, C.M. et al. 2000. The 5-HT(3) receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised rat. Gut 46 : 474 480.
37. Zhai, Q.Z. & R.J. Traub. 1999. The NMDA receptor antagonist MK-801 attenuates c-Fos expression in the lumbosacral spinal cord following repetitive noxious and non-noxious colorectal distention. Pain 83 : 321 329.
38. Traub, R.J., S. Stitt & G.F. Gebhart. 1995. Attenuation of c-Fos expression in the rat lumbosacral spinal cord by morphine or tramadol following noxious colorectal distention. Brain Res. 701 : 175 182.
39. Traub, R.J., T. Herdegen & G.F. Gebhart. 1993. Differential expression of c-fos and c-jun in two regions of the rat spinal cord following noxious colorectal distention. Neurosci. Lett. 160 : 121 125.
40. Lazovic, J. et al. 2005. Regional activation in the rat brain during visceral stimulation detected by c-fos expression and fMRI. Neurogastroenterol. Motil. 17 : 548 556.
41. Ohashi, K. et al. 2008. MicroPET detection of regional brain activation induced by colonic distention in a rat model of visceral hypersensitivity. J. Vet. Med. Sci. 70 : 43 49.
42. Wang, Z. et al. 2008. Regional brain activation in conscious, nonrestrained rats in response to noxious visceal stimulation. Pain 138 : 233 243.
43. Berman, S.M. et al. 2006. Sex differences in regional brain response to aversive pelvic visceral stimuli. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291 : R268 276.
44. Naliboff, B.D. et al. 2006. Longitudinal change in perceptual and brain activation response to visceral stimuli in irritable bowel syndrome patients. Gastroenterology 131 : 352 365.
45. Kern, M.K. et al. 2001. Gender differences in cortical representation of rectal distension in healthy humans. Am. J. Physiol. Gastrointest. Liver Physiol. 281 : G1512 1523.
46. Guo, Y. et al. 2008. Sex differences in regional functional brain activation elicited by colorectal distention in conscious, nonrestrained rats. In Digestive Disease Week (Abstr.#436695). San Diego, CA.
47. Wang, Z. et al. 2008. Assessment of functional brain activation in expectation of visceral pain in a rat step-down passive avoidance model. In Digestive Disease Week (Abstr. #437215). San Diego, CA.
48. McIntosh, A.R. & F. Gonzalez-Lima. 1998. Large-scale functional connectivity in associative learning: interrelations of the rat auditory, visual, and limbic systems. J. Neurophysiol. 80 : 3148 3162.
49. Borsook, D. et al. 2007. CNS response to a thermal stressor in human volunteers and rats may predict the clinical utility of analgesics. Drug. Dev. Res. 68 : 23 41.
50. Wise, R.G. & I. Tracey. 2006. The role of fMRI in drug discovery. J. Magn. Reson. Imaging 23 : 862 876.